Coherus Biosciences | CHRS - Market Capitalization

Stock Price
1.99
Daily Change
0.24 13.71%
Monthly
16.37%
Yearly
95.10%
Q2 Forecast
1.71

Coherus Biosciences reported $224.9M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 5.66B 217M May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Fujifilm JPY 4.03T 548.71B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
Merck USD 297.1B 35.84B Mar/2026
Myriad Genetics USD 575M 98M Dec/2025
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Vertex Pharmaceuticals USD 113.8B 213M May/2026
Xencor USD 795M 98M May/2026
Zoetis USD 39.98B 9.73B May/2026